CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 4 Option exercise Director acquired 3,498,200 shares (option exercise)
- 10-Q Report Quarterly Report
- 4 Option exercise Chief Financial Officer acquired 245,450 shares (option exercise)
- 8-K Event Auditor change
- 8-K Event Material agreement · Unregistered share sale
- 4 Other acquisition Director acquired 400,000 shares (other)
- 8-K Event Material agreement · Unregistered share sale
- 4 Conversion Director acquired 4,491,310 shares (conversion)
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · Unregistered share sale
- D Other Notice of Sales of Unregistered Securities
- 4 Other acquisition 10% owner acquired 1,000,000 shares (other)
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition Director acquired 400,000 shares (other)
- 4 Option exercise Director acquired 10,838,809 shares (option exercise)
- SC 13G Stake Amended Statement of Ownership
- 4 Option exercise 10% owner acquired 5,500,212 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
Page 38 of 63 · 1,250 filings